Highlights
NASDAQ: VCEL       Vericel Corproation
Last Price Today's Change   Day's Range   Trading Volume
18.905   -0.30 (1.56%)  18.706 - 19.15  85,016

Overview

 
Avg Volume (4 weeks):451,815
4 Weeks Range:14.84 - 19.565
4 Weeks Price Volatility (%):
86.03%
52 Weeks Range:13.40 - 21.005
52 Weeks Price Volatility (%):
72.39%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

  Be the first to like this.
 


 

2874  2730  455  2911 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.703+0.033 
 FCEL 0.827+0.282 
 AMD 37.512+0.802 
 AABA 19.630.00 
 ET 11.045-0.615 
 GE 11.235-0.185 
 DIS 146.75+8.17 
 BAC 32.694-0.396 
 I 15.56-4.83 
 UBER 26.58-0.12 
Partners & Brokers